Skip to main content
Search

University of Louisville

2 related articles

Subscribe to updates
  1. A 45-member modified Delphi consensus: screen for eating disorders before GLP-1 receptor agonist prescribing, and generally avoid these agents in active anorexia and bulimia nervosa

    Using a three-round modified Delphi method, a 45-member panel of clinicians and researchers in diabetes, obesity and/or eating disorders plus people with lived experience reached an average 91.7% consensus on recommendations for GLP-1 receptor agonist use in eating disorder contexts, covering pre-treatment screening, risk-stratified monitoring, standardized educational materials and concurrent evidence-based psychotherapy, stating that these agents should generally be avoided in active eating disorders, particularly anorexia nervosa, atypical anorexia nervosa and bulimia nervosa with marked dietary restraint and/or significant weight suppression, and setting out research priorities in epidemiology, regulation and binge eating disorder trials.

  2. Bibliometric analysis of 608 AI breast cancer imaging studies finds diagnosis at 71.22% and explainable AI with a 1.00 burst ratio as the hottest frontier

    Using Scopus and Web of Science and a PRISMA workflow that narrowed 4,831 records to 608 peer-reviewed journal articles and reviews from 2020 to 2026, this study applied Bibliometrix and VOSviewer for a task-aware, methodology-centric bibliometric and thematic analysis, finding that diagnosis accounts for 71.22% of studies, mammography for 42.11%, explainable AI shows the strongest burst ratio at 1.00, while treatment-response prediction covers only 2.30% and only about 15-25% of studies explicitly report hyperparameter tuning strategies.

You’re all caught up